Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®*, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
On After a slow start to the 2024/25 financial year, Südzucker AG expects a significant decline in EBITDA and operating…
Last year, the five-year research project "Shape-variable wing systems for gliders (MILAN)", which was funded by the Fed…
First-ever all-electric BMW 5 Series for the BMW Open champion 2024 Winner’s Car produced in BMW Group Plant Dingolfing…
WAN-IFRA announced the 2024 Digital Media Americas Awards winners in Panama City as part of its annual Digital Media LAT…
Around one hundred exhibitors from 11 countries are geared up for one of Ethiopia’s top business events. The 6th edition…
It is certainly going to be a very special edition, the 31st Iran agrofood. Around seven hundred exhibitors from 15 coun…
Within the realm of modern technology, cameras have progressed from mere devices capturing visible light to sophisticate…
Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to provide an update on its first…
hofer powertrain, a key development and technology partner for the automotive industry, announces a significant expansio…